Share This Video

Diabetes in America: The Beta Cell in Type 2 Diabetes

In this video, Dr. Leahy reviews the current understanding of beta-cell failure in type 2 diabetes.
Jack L. Leahy, MD
Professor of Medicine and Chief of Endocrinology, Diabetes, and Metabolism Unit
University of Vermont College of Medicine
Burlington, Vermont
Jack L. Leahy, MD


  1. Bergenstal RM, Kendal DM, Franz MJ, Rubenstein AH. Management of type II diabetes: a systematic approach to meeting the standards of care. II: oral agents, insulin, and management of complications. In: De Groot LJ, Jameson JL, eds. Endocrinology. 4th ed. Philadelphia, PA: WB Saunders; 2001.
  2. Lebovitz HE. Insulin secretagogues: old and new. Diabetes Rev. 1999;7(3):139-153.
  3. Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA. ß-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab. 2005;90(1):493-500.
  4. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52(1):102-110.
  5. Leahy JL. Pathogenesis of type 2 diabetes mellitus. Arch Med Res. 2005;36(3):197-209.
  6. Wajchenberg BL. Beta-cell failure in diabetes and preservation by clinical treatment. Endocr Rev. 2007;28(2):187-218.
  7. Donath MY, Ehses JA, Maedler K, et al. Mechanisms of ß-cell death in type II diabetes. Diabetes. 2005;54(suppl 2):S108-S113.
  8. Donath MY, Gross DJ, Cerasi E, Kaiser N. Hyperglycemia-induced ß-cell apoptosis in pancreatic islets of Psammomys obersus during development of diabetes. Diabetes. 1999;48(4):738-744.
  9. Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 1993;42(11):1663-1672.